Cytokinetics, Inc. hosted a Research and Development Day on Wednesday, December 12, 2012 at the New York Grand Hyatt Hotel in New York City. If you weren’t able to attend in person, you can listen to a recording of the conference by phone. Learn more about how to access the replay of the conference by clicking the link below. Cytokinetics is currently recruiting participants for their Phase IIb study of tirasemtiv in people with ALS. Cytokinetics plans to enroll around 400 people with ALS in the clinical trial.
Click here to read more.Share this: